期刊文献+

肿瘤化疗中止吐药物的合理应用 被引量:24

The Reasonable Application of Antiemetic in Tumor Chemotherapy
下载PDF
导出
摘要 目的通过对化疗引起恶心呕吐的机理及止吐药物等相关方面的综述,为临床合理使用止吐药物提供参考。方法通过回顾性研究国内外相关临床试验和有关文献,对CINV的类型及其发生机制,止吐药物的种类、作用机制、药代动力学、联合用药、注意事项及临床应用等方面进行阐述。结果针对患者的具体情况及不同的CINV类型,选择不同的止吐方案,可以达到较好的止吐效果,5-HT3受体拮抗剂联合其他作用机制不同的止吐药物已经成为治疗急性CINV的首选一线方案,但对难治性CINV和延迟性CINV的治疗效果尚不理想。结论须对化疗致吐机制进行深入研究,开发新型止吐药物,单用或联合使用不同作用机制药物,采用个体化用药的手段,有效控制各种CINV,达到用药合理性与经济性的统一。 Objective To review the mechanism of nausea and vomiting caused by chemotherapy and antiemetic so as to guide clinical rational use of antiemetic. Methods The type of CINV, its mechanism, the type of antiemetic drugs, mechanism of action, pharmaeokinetics, drug combination, notes, and clinical applications were explained by retrospective study on clinical trials and the literature at home and abroad. Results Different antiemetie plans were selected according to specific conditions of patients and different types of CINV, so as to achieve a better antiemetic effect. 5-HT3 receptor antagonist in combination with other antiemetic of various mechanisms has become the first-line for treating acute CINV, but the therapeutic effect on refractory CINV and delayed CINV is not yet ideal. Conclusion Deep study shall be conducted on the mechanism of nausea and vomiting caused by chemotherapy, as well as development on novel antiemetic, single-use or combination use of antiemetic, and personalized medicine, so as to control different CINV effectively, and realize the unify of rationality and economy.
出处 《中国药事》 CAS 2013年第2期209-214,共6页 Chinese Pharmaceutical Affairs
关键词 肿瘤化疗 止吐药物 恶心呕吐 作用机制 合理应用 tumor chemotherapy antiemetic CINV mechanism reasonable application
  • 相关文献

参考文献31

  • 1Wiser W, Berger A. Practical management of chemothera- py induced nausea and vomiting [J]. Oneology (Williston Park), 2005, 19.. 637-638.
  • 2Aapro M. Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in pa- tients receiving highly emetogenic chemotherapy (HEC) [J]. Support Care Cancer, 2003, 11:117 119.
  • 3Coates A, Abraham S, Kaye SB, et al. On the receiving end: patient perceptions of the side-effects of cancer chemo- therapy [J]. EurJ Cli Oneol, 1984, 19:203- 205.
  • 4Wijingaarden 1V, Tulp MTHM, Soudijin W. Serotoninago- nists and antagonists pharmacogical tools [J]. Recl Tray Chim Pays-Bas, 1993, 112-126.
  • 5Gothert M. 5-tlydroxytryptamine receptors. Arzneim. Forsch [J]. Drug Res, 1992, 42 (1) (2a): 238-243.
  • 6Matsuki N. Mechanisms of cytotoxic drug induced emeis and its prevention [J]. Ya kuga ku zasshi, 1996, 116:710-718.
  • 7Elizabeth G R, Ettinger D S. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomi- ting [J]. Drugs, 1998, 55 (2): 173-189.
  • 8Singh L, Field M J, Hughes J, et al. The tachykinin NK1 receptor antagonist PD154075 blocks cisplatin-induced de- layed emesis in the ferret [J]. Eur Pharmacol, 1997, 321 (2) : 209-216.
  • 9黄红兵,林桐榆.肿瘤治疗止吐药物临床应用研究进展[J].中华肿瘤防治杂志,2007,14(21):1675-1678. 被引量:12
  • 10邹燕梅,于世英.NCCN止吐临床指引(2005.1版)[J].循证医学,2006,6(1):54-64. 被引量:32

二级参考文献88

  • 1陈晓品,张菊,戴晓波,张玲,吴永忠,张涛,朱宇熹,甘露.托烷司琼对化疗治疗癌症防治呕吐的临床研究[J].中国药师,2004,7(7):551-553. 被引量:1
  • 2杨建生.恶性肿瘤化疗后胃肠道反应中医辨证论治分析[J].湖南中医杂志,1993,9(4):9-10. 被引量:17
  • 3邹燕梅,于世英.NCCN止吐临床指引(2005.1版)[J].循证医学,2006,6(1):54-64. 被引量:32
  • 4周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,1997,1.417.
  • 5[1]Wiser W,Berger A.Practical management of chemotherapy-induced nausea and vomiting.Oncology Williston Park),2005,19:637
  • 6[2]Aapro M,et al.Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in patients recieving highly emetogenic chemotherapy (HEC)[Abstract].Support Care Cancer,2003,11:A17
  • 7[3]Jordan K,Kasper C,Schmoll HJ.Chemotherapy-induced nausea and vomiting:Current and new standards in the antiemetic prophylaxis and treatment.Eur J Cancer,2005,41:199
  • 8[4]Roila F,Donati D,Tamberi S,et al.Delayed emesis:Incidence,pattern,prognostic factors and optimal treatment.Support Care Cancer,2002,10:88
  • 9[5]website:http//www.mascc.org.Multinational association for supportive care in cancer.Consensus Conference on antiemitic therapy Perugia,2004,March 29-31
  • 10[6]Hesketh PJ,Kris MG,Grunberg SM,et al.Proposal for classifying the acute emetogenicity of cancer chemotherapy.J Clin Oncol,1997,15:103

共引文献213

同被引文献244

引证文献24

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部